Skip to main content
Caplight Logo









Nalagenetics

Nalagenetics

Private
SingaporeHealthcare & Life Scienceshttps://www.nalagenetics.com/en

Last Round

Series A

Mar 25, 2022

Total Funding Raised

$13.6M

Company Overview

Nalagenetics is a biotechnology company that provides genetic testing and clinical decision support software to enable personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

clinical decision supportpharmacogenomicsCDSPGxAsian geneticsgenetic testingprecision medicineadverse drug reactionbioinformatics softwaremedical AIcancer risk screeninghereditary cancer testingnutrigeneticspolygenic risk scoresNIPT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nalagenetics Comparables

Compare Nalagenetics with similar companies based on industry and business-model similarity.

Nalagenetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qiagen
79%
Geneyx
77%
Aranscia
77%

Nalagenetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 25, 2022
Pre SeedNov 1, 2018

Nalagenetics Investors

Notable investors and investment history

Nalagenetics investors
InvestorRounds
Intudo VenturesPre Seed, Series A
AngelCentralPre Seed
Integra PartnersSeries A
Accelerate Technologies Pte LtdSeries A
Vulcan CapitalSeries A
East VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors increased 49% MoM, reaching 6.4K.

  • Jul 24, 2023

    Grew 20% QoQ, from 80 to 96 employees.

Nalagenetics Filings

Explore SEC and related filing metadata, where available.

Nalagenetics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nalagenetics's valuation, stock price, and market status.

Is Nalagenetics a public or private company?

Nalagenetics is a private company.

What is the current stock price of Nalagenetics?

Nalagenetics is a private company with no public stock price. No recent secondary market data is available.

How much is Nalagenetics worth (valuation)?

Valuation information for Nalagenetics is not publicly available.

Can I buy Nalagenetics stock?

Nalagenetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nalagenetics's last funding round?

Nalagenetics's most recent funding round was Series A on March 25, 2022.

Who are the main investors in Nalagenetics?

Key investors in Nalagenetics include Intudo Ventures, Vulcan Capital, East Ventures.

Will Nalagenetics IPO soon?

No public IPO plans have been announced for Nalagenetics.

How can I track Nalagenetics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nalagenetics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range41
Year Founded2016
Last FundingMar 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?